Pain – NSAIDS

  • Zorvolex 2017 report

    Zorvolex 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 32 Pages The 5 Key Questions Addressed by this Report:...

  • Caldolor 2016 report

    Caldolor 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 28 Pages The 5 Key Questions Addressed by this Report:...

  • Duexis 2016 report

    Duexis 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 32 Pages The 5 Key Questions Addressed by this Report:...

  • Dyloject 2016 report

    Dyloject 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Flector Patch 2016 report

    Flector Patch 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 26 Pages The 5 Key Questions Addressed by this...

  • Ofirmev 2016 report

    Ofirmev 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 28 Pages The 5 Key Questions Addressed by this Report:...

  • Pennsaid 2016 report

    Pennsaid 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 30 Pages The 5 Key Questions Addressed by this Report:...

  • Sprix 2016 report

    Sprix 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 32 Pages The 5 Key Questions Addressed by this Report:...

  • Voltaren Gel 2016 report

    Voltaren Gel 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 30 Pages The 5 Key Questions Addressed by this...

  • Zipsor 2016 report

    Zipsor 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 30 Pages The 5 Key Questions Addressed by this Report:...

  • Zorvolex 2016 report

    Zorvolex 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 28 Pages The 5 Key Questions Addressed by this Report:...

  • Caldolor 2015 report

    Caldolor 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 27 Pages The 5 Key Questions Addressed by this...